EDGAR Filing Documents for 0001193125-14-131643

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-14-131643

Filing Date

2014-04-04

Accepted

2014-04-04 15:46:54

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d704824ds3.htm	S-3	289768
2	EX-4.3	d704824dex43.htm	EX-4.3	287126
3	EX-4.4	d704824dex44.htm	EX-4.4	93614
4	EX-4.5	d704824dex45.htm	EX-4.5	94833
5	EX-4.6	d704824dex46.htm	EX-4.6	90289
6	EX-5.1	d704824dex51.htm	EX-5.1	22682
7	EX-23.1	d704824dex231.htm	EX-23.1	2510
8	GRAPHIC	g704824cov_pg001.jpg	GRAPHIC	8595
9	GRAPHIC	g704824ex5_1.jpg	GRAPHIC	6265
	Complete submission text file	0001193125-14-131643.txt		902773

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020

Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200

ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)